US Stock MarketDetailed Quotes

CUE Cue Biopharma

Watchlist
  • 1.040
  • -0.040-3.70%
Close Dec 27 16:00 ET
65.88MMarket Cap-1.14P/E (TTM)

Cue Biopharma Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
58.86%3.34M
92.33%2.66M
818.18%1.72M
340.96%5.49M
1,105.96%1.82M
2,988.24%2.1M
5,215.38%1.38M
-81.30%187K
-91.67%1.25M
-98.17%151K
Operating revenue
58.86%3.34M
92.33%2.66M
818.18%1.72M
340.96%5.49M
1,105.96%1.82M
2,988.24%2.1M
5,215.38%1.38M
-81.30%187K
-91.67%1.25M
-98.17%151K
Cost of revenue
Gross profit
Operating expense
-9.40%12.25M
-12.47%13.04M
6.03%14.39M
5.00%57.48M
3.06%15.5M
21.80%13.52M
11.40%14.9M
-10.97%13.57M
-6.66%54.75M
-6.88%15.04M
Selling and administrative expenses
-21.34%2.87M
-17.37%3.51M
0.24%4.19M
3.16%16.68M
24.43%4.61M
3.32%3.65M
12.35%4.25M
-19.01%4.18M
-6.57%16.17M
-20.29%3.7M
-General and administrative expense
-21.34%2.87M
-17.37%3.51M
0.24%4.19M
3.16%16.68M
24.43%4.61M
3.32%3.65M
12.35%4.25M
-19.01%4.18M
-6.57%16.17M
-20.29%3.7M
Research and development costs
-4.99%9.38M
-10.52%9.53M
8.60%10.2M
5.76%40.8M
-3.93%10.89M
30.42%9.87M
11.03%10.65M
-6.85%9.39M
-6.70%38.58M
-1.47%11.33M
Operating profit
21.95%-8.91M
23.19%-10.38M
5.32%-12.67M
2.82%-51.99M
8.13%-13.68M
-3.52%-11.42M
-1.27%-13.52M
6.03%-13.38M
-22.40%-53.5M
-88.58%-14.89M
Net non-operating interest income expense
-62.56%155K
-36.14%212K
18.45%321K
558.60%1.42M
45.26%398K
444.74%414K
381.36%332K
1,694.12%271K
368.43%215K
6,929.25%274K
Non-operating interest income
-51.00%343K
-24.29%427K
-12.32%562K
186.75%2.66M
43.20%905K
250.00%700K
540.91%564K
7,912.50%641K
1,921.87%928K
16,113.44%632K
Non-operating interest expense
-34.27%188K
-7.33%215K
-34.86%241K
74.61%1.25M
41.62%507K
130.65%286K
12.62%232K
1,380.00%370K
--713K
--358K
Other net income (expense)
97K
-156.68%-157K
277K
19K
Special income (charges)
--97K
----
----
-156.68%-157K
-926.32%-157K
--0
----
----
--277K
--19K
-Gain on sale of property,plant,equipment
--97K
----
----
-156.68%-157K
---157K
--0
----
----
--277K
----
Income before tax
21.31%-8.66M
22.86%-10.17M
5.81%-12.35M
4.30%-50.73M
7.94%-13.43M
-0.46%-11.01M
0.17%-13.19M
8.04%-13.11M
-21.40%-53.01M
-84.96%-14.59M
Income tax
Net income
21.31%-8.66M
22.86%-10.17M
5.81%-12.35M
4.30%-50.73M
7.94%-13.43M
-0.46%-11.01M
0.17%-13.19M
8.04%-13.11M
-20.04%-53.01M
-74.04%-14.59M
Net income continuous Operations
21.31%-8.66M
22.86%-10.17M
5.81%-12.35M
4.30%-50.73M
7.94%-13.43M
-0.46%-11.01M
0.17%-13.19M
8.04%-13.11M
-20.04%-53.01M
-74.04%-14.59M
Minority interest income
Net income attributable to the parent company
21.31%-8.66M
22.86%-10.17M
5.81%-12.35M
4.30%-50.73M
7.94%-13.43M
-0.46%-11.01M
0.17%-13.19M
8.04%-13.11M
-20.04%-53.01M
-74.04%-14.59M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
21.31%-8.66M
22.86%-10.17M
5.81%-12.35M
4.30%-50.73M
7.94%-13.43M
-0.46%-11.01M
0.17%-13.19M
8.04%-13.11M
-20.04%-53.01M
-74.04%-14.59M
Basic earnings per share
29.17%-0.17
31.03%-0.2
13.79%-0.25
25.50%-1.11
23.68%-0.29
22.58%-0.24
21.62%-0.29
34.09%-0.29
-5.67%-1.49
-52.00%-0.38
Diluted earnings per share
29.17%-0.17
31.03%-0.2
13.79%-0.25
25.50%-1.11
23.68%-0.29
22.58%-0.24
21.62%-0.29
34.09%-0.29
-5.67%-1.49
-52.00%-0.38
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Total revenue 58.86%3.34M92.33%2.66M818.18%1.72M340.96%5.49M1,105.96%1.82M2,988.24%2.1M5,215.38%1.38M-81.30%187K-91.67%1.25M-98.17%151K
Operating revenue 58.86%3.34M92.33%2.66M818.18%1.72M340.96%5.49M1,105.96%1.82M2,988.24%2.1M5,215.38%1.38M-81.30%187K-91.67%1.25M-98.17%151K
Cost of revenue
Gross profit
Operating expense -9.40%12.25M-12.47%13.04M6.03%14.39M5.00%57.48M3.06%15.5M21.80%13.52M11.40%14.9M-10.97%13.57M-6.66%54.75M-6.88%15.04M
Selling and administrative expenses -21.34%2.87M-17.37%3.51M0.24%4.19M3.16%16.68M24.43%4.61M3.32%3.65M12.35%4.25M-19.01%4.18M-6.57%16.17M-20.29%3.7M
-General and administrative expense -21.34%2.87M-17.37%3.51M0.24%4.19M3.16%16.68M24.43%4.61M3.32%3.65M12.35%4.25M-19.01%4.18M-6.57%16.17M-20.29%3.7M
Research and development costs -4.99%9.38M-10.52%9.53M8.60%10.2M5.76%40.8M-3.93%10.89M30.42%9.87M11.03%10.65M-6.85%9.39M-6.70%38.58M-1.47%11.33M
Operating profit 21.95%-8.91M23.19%-10.38M5.32%-12.67M2.82%-51.99M8.13%-13.68M-3.52%-11.42M-1.27%-13.52M6.03%-13.38M-22.40%-53.5M-88.58%-14.89M
Net non-operating interest income expense -62.56%155K-36.14%212K18.45%321K558.60%1.42M45.26%398K444.74%414K381.36%332K1,694.12%271K368.43%215K6,929.25%274K
Non-operating interest income -51.00%343K-24.29%427K-12.32%562K186.75%2.66M43.20%905K250.00%700K540.91%564K7,912.50%641K1,921.87%928K16,113.44%632K
Non-operating interest expense -34.27%188K-7.33%215K-34.86%241K74.61%1.25M41.62%507K130.65%286K12.62%232K1,380.00%370K--713K--358K
Other net income (expense) 97K-156.68%-157K277K19K
Special income (charges) --97K---------156.68%-157K-926.32%-157K--0----------277K--19K
-Gain on sale of property,plant,equipment --97K---------156.68%-157K---157K--0----------277K----
Income before tax 21.31%-8.66M22.86%-10.17M5.81%-12.35M4.30%-50.73M7.94%-13.43M-0.46%-11.01M0.17%-13.19M8.04%-13.11M-21.40%-53.01M-84.96%-14.59M
Income tax
Net income 21.31%-8.66M22.86%-10.17M5.81%-12.35M4.30%-50.73M7.94%-13.43M-0.46%-11.01M0.17%-13.19M8.04%-13.11M-20.04%-53.01M-74.04%-14.59M
Net income continuous Operations 21.31%-8.66M22.86%-10.17M5.81%-12.35M4.30%-50.73M7.94%-13.43M-0.46%-11.01M0.17%-13.19M8.04%-13.11M-20.04%-53.01M-74.04%-14.59M
Minority interest income
Net income attributable to the parent company 21.31%-8.66M22.86%-10.17M5.81%-12.35M4.30%-50.73M7.94%-13.43M-0.46%-11.01M0.17%-13.19M8.04%-13.11M-20.04%-53.01M-74.04%-14.59M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 21.31%-8.66M22.86%-10.17M5.81%-12.35M4.30%-50.73M7.94%-13.43M-0.46%-11.01M0.17%-13.19M8.04%-13.11M-20.04%-53.01M-74.04%-14.59M
Basic earnings per share 29.17%-0.1731.03%-0.213.79%-0.2525.50%-1.1123.68%-0.2922.58%-0.2421.62%-0.2934.09%-0.29-5.67%-1.49-52.00%-0.38
Diluted earnings per share 29.17%-0.1731.03%-0.213.79%-0.2525.50%-1.1123.68%-0.2922.58%-0.2421.62%-0.2934.09%-0.29-5.67%-1.49-52.00%-0.38
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion with Explanatory Notes--------Unqualified Opinion--
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Symbol Mini Chart % Chg
Ecopetrol
EC
0.00%
Petroleo Brasileiro SA Petrobras
PBR
-0.13%
Vale SA
VALE
-0.45%
Meta Platforms
META
-0.59%
Adobe
ADBE
-0.82%

Unlock the Full List